Characterisation of monoclonal antibodies in cell supernatants by 2D-LC/MS
Location
Analytical Technologies Europe 2020 & Antibody Industrial Symposium 2020
Development of characterisation and potency assays for immunotherapy products
Download the posterOligonucleotides: Absolute quantification and P=O/P=S in a single ICP-MS/MS run
Location
TIDES 2018
Epitope mapping of an interleukin receptor for three therapeutic antibodies by HDX-MS
Location
Analytical Technologies Europe 2018
Bioanalysis of 9 elemental impurities in human whole blood and urine samples by ICP-MS
Location
EBF Open Symposium 2017
Mass Spectrometry as a tool for the Bioanalysis of Antibody-Drug Conjugates (ADCs)
Location
EBF Open Symposium 2017
Development and optimization of a TNFα neutralizing assay using a Quality by Design approach
Location
BEBPA 2017
Absolute quantification of proteins & mAbs by ICP-MS
Location
Analytical Technologies Europe 2017
State-of-the art LC/MS methods applied to the characterisation of a highly-glycosylated fusion protein: Etanercept
Location
Analytical Technologies Europe 2017
Multi-level mass spectrometric characterisation of Antibody-Drug Conjugates in a regulated environment
Location
Analytical Technologies Europe 2017
Development and use of 2D-LC/MS as a versatile and powerful tool for the analysis of mAbs and ADCs in a regulated environment
Location
Analytical Technologies Europe 2016
Characterizing Deamidation and Oxidation in Adalimumab with Low pH Peptide Mapping and Middle-Up Mass Spec Analysis.
Location
ASMS Sanibel Conference 2016
Surface Plasmon Resonance assay for characterisation of therapeutic monoclonal antibodies
Location
European Antibody Congress 2015
Elemental impurities: how to be compliant with ICH Q3D guideline?
Location
CPhI ISCE 2015
Validation of a method for the quantification of Influenza hemagglutininin vaccine samples using surface plasmon resonance
Download the posterComparison of multiplex assays for the quantification of cytokines
Location
ISCT 2015
How to manage the dilution effect observed in the quantification of residual CHO host cell proteins using commercialized ELISA kits?
Location
BEBPA HCP workshop 2014
Fine characterization of therapeutic antibody Trastuzumab by UHPLC-ESI-QTOF-MSE peptide mapping using reversed-phase and HILIC separation modes
Location
ASMS 2012
Immunogenicity assay development for biopharmaceuticals requires a case-by-case approach
Location
EBF Focus meeting 2011
Combination of GC, UPLC, CE and MS for the characterization of monoclonal antibody glycosylation
Location
Bioprocess International 2010